Mural Oncology News and Activities

Acquisition, funding and merger involving Mural Oncology.

• Xoma Royalty has acquired Mural Oncology (posted on December 8 2025).

View the org chart displaying its 13 main executives

Most searched biographies at Mural Oncology

• Caroline Loew, Chief Executive Officer and Director
• Benjamin Hickey, Director
• Susan Altschuller, Director

Popular executive movements at Mural Oncology

• Vicki Goodman, Chief Medical Officer, will leave the company on Apr. 6, 2026  (posted on March 25 2026).
• Sachiyo Minegishi, Director, has left the company  (posted on January 6 2026).
• Ryan Bis, Vice President, Corporate Controller, has left the company  (posted on December 8 2025).

Create your alert
to follow the executive moves at Mural Oncology.

Mural Oncology has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Mural Oncology

Social media about Mural Oncology

• Mural Oncology on Wikipedia, Google News & Yahoo Finance
• Mural Oncology on LinkedIn, X (Twitter) & YouTube